Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
6.44
+0.01 (0.16%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Minerva Neurosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 282 | 174 | 16 | 43 | 8 | 34 | |
| Market Cap Growth | 2695.47% | 1019.70% | -63.88% | 406.53% | -75.19% | -65.73% | |
| Enterprise Value | 260 | 222 | 49 | 76 | 40 | 33 | |
| Last Close Price | 6.44 | 4.02 | 2.22 | 6.15 | 1.59 | 6.41 | |
| PE Ratio | - | - | 10.80 | - | - | - | |
| PB Ratio | - | -1.28 | -0.60 | -1.51 | -0.42 | 4.29 | |
| Debt / Equity Ratio | -0.44 | -0.44 | -2.33 | -2.88 | -3.68 | 8.32 | |
| Net Debt / Equity Ratio | 0.16 | 0.16 | -1.50 | -1.44 | -1.88 | 0.70 | |
| Net Debt / EBITDA Ratio | 1.48 | 1.48 | -1.77 | -1.78 | - | -0.18 | |
| Net Debt / FCF Ratio | 1.65 | 1.65 | -1.98 | -2.78 | -1.53 | -0.23 | |
| Quick Ratio | 35.93 | 35.93 | 7.53 | 12.25 | 28.46 | 21.55 | |
| Current Ratio | 36.28 | 36.28 | 7.85 | 12.57 | 29.15 | 22.07 | |
| Return on Equity (ROE) | - | - | - | - | - | -164.60% | |
| Return on Assets (ROA) | -13.97% | -13.97% | -29.04% | -25.81% | -23.86% | -27.98% | |
| Return on Capital Employed (ROCE) | -15.80% | -15.80% | -63.70% | -43.20% | -47.00% | -40.60% | |
| Earnings Yield | -103.92% | -168.67% | 9.26% | -69.77% | -378.15% | -145.84% | |
| FCF Yield | -4.79% | -7.77% | -125.84% | -34.38% | -290.45% | -71.89% | |
| Buyback Yield / Dilution | -11.75% | -11.75% | -16.41% | -21.84% | 0.00% | -4.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.